TELA Bio faces Nasdaq delisting notice after failing $1 minimum bid rule

• TELA Bio received a Nasdaq delisting notice tied to the $1 minimum bid rule, following a 180-day compliance deadline that ended Sept. 14, 2026.
• Nasdaq warned on Sept. 15, 2026 that the shares face delisting unless the company requests a hearing with a Nasdaq Hearings Panel.
• The planned hearing request would stay any suspension or delisting while the process runs, keeping the stock trading on Nasdaq.
• Regaining compliance requires a closing bid of at least $1 for 10 consecutive business days, or up to 20 at Nasdaq’s discretion.
• A reverse stock split vote is set for Oct. 8, 2026, with a proposed range of 1-for-5 to 1-for-15.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-108935), on September 18, 2026, and is solely responsible for the information contained therein.